Tag: <span>RSV</span>

Home / RSV
Post

RSV Vaccines Will Carry Warning for Guillain-Barré Syndrome

Heidi Splete January 22, 2025 461363 The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased risk for Guillain-Barré Syndrome (GBS) within 42 days of vaccination based on data from postmarketing research, according to a safety communication from the US Food and Drug Administration (FDA). Concerns about GBS arose...

Post

Immunocompromised may not produce enough protective antibodies against RSV after vaccination, says new study

by Johns Hopkins University School of Medicine Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) and tagged with antibodies (colorized yellow) against the virus’ fusion protein — the target of RSV vaccines. Credit: National Institute of Allergy and Infectious Diseases, National Institutes of Health Johns Hopkins Medicine researchers have shown that people...

Post

RSVpreF vaccine found effective in preventing severe RSV in older adults

by Elana Gotkine Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract disease (LRTD) among adults aged 60 years or older, according to a study published online Dec. 13 in JAMA Network Open. Sara Y. Tartof, Ph.D., M.P.H., from Kaiser Permanente Southern California in Pasadena, and colleagues estimated RSVpreF vaccine effectiveness in older adults in...

Post

CDC study shows nirsevimab effective in reducing RSV hospitalizations among young children

by Justin Jackson , Medical Xpress Transmission electron micrograph of RSV. Credit: CDC/ Dr. Erskine Palmer / Public Domain Research led by the CDC and conducted at seven academic pediatric medical centers in the United States finds nirsevimab (sold as Beyfortus) highly effective in reducing respiratory syncytial virus (RSV) related hospitalization in children under 5...

RSV found to infect nerve cells & may cause inflammatory nerve damage
Post

RSV found to infect nerve cells & may cause inflammatory nerve damage

By Paul McClure Researchers have found that RSV, very common in children, can also infect and damage nerve tissue Depositphotos Thought only to infect the respiratory tract, new research has proved for the first time that the respiratory syncytial virus (RSV), very common in young children, can also penetrate nerve cells directly, triggering excessive inflammation and...

RSV shown to infect nerve cells, cause inflammation and damage
Post

RSV shown to infect nerve cells, cause inflammation and damage

by Tulane University Transmission electron micrograph of RSV. Credit: CDC/ Dr. Erskine Palmer / Public DomainRespiratory syncytial virus (RSV), a common infection in children and senior adults, can also infect nerve cells and trigger inflammation leading to nerve damage, according to a new Tulane University study. RSV can cause mild symptoms such as coughing, sneezing and...

US approves maternal vaccine to prevent RSV in infants
Post

US approves maternal vaccine to prevent RSV in infants

Credit: CC0 Public Domain The United States on Monday became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies. The Pfizer shot, which was already approved for use in older adults, has now been greenlighted for use as a single injection from...

Researchers discover antibody that neutralizes both RSV and human metapneumovirus
Post

Researchers discover antibody that neutralizes both RSV and human metapneumovirus

by Anthony Czelusniak, Vanderbilt University James Crowe, Jr., MD, left, and Naveenchandra Suryadevara, PhD, have discovered a monoclonal antibody with therapeutic potential that neutralizes both RSV and hMPV. Credit: Vanderbilt University Vanderbilt University Medical Center and Stanford University researchers discovered a potent, cross-neutralizing human monoclonal antibody against the respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). The findings,...

FDA approves first RSV vaccine, a long-sought scientific achievement
Post

FDA approves first RSV vaccine, a long-sought scientific achievement

By Helen Branswell May 3, 2023 Reprints KENZO TRIBOUILLARD/AFP VIA GETTY IMAGES The Food and Drug Administration on Wednesday licensed the first-ever vaccine for respiratory syncytial virus, or RSV, completing an elusive quest that has been decades in the making. The product, GSK’s Arexvy, was approved for adults ages 60 and older. GSK beat a crowded field of...

Study finds RSV may evade vaccines via rapid mutation
Post

Study finds RSV may evade vaccines via rapid mutation

by Bill Snyder, Vanderbilt University Seasonality of RSV cases in children hospitalized with lower respiratory tract infection in Buenos Aires between 2014 and 2017. (A) A cumulative bar graph of the number of positive cases of respiratory viruses detected per month per year. Dotted lines represent the minimum and maximum temperatures recorded per month per...

  • 1
  • 2